(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PI-VIEW

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PI-VIEW

ST13

US500000097661016

Classe

9, 10

Pedido

97661016

Registro

7963413

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

19/06/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 10

Data de depósito

03/11/2022

Data de registro

30/09/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/09/2025

Última transação

19/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Seoul, KR

Examinador

WHELAN, JAIME M

Localização atual

Historical data usage

Titulares e representantes

Titulares

Proteina Co., Ltd.

Representantes

Hun Joon Kim LEX IP MEISTER, PLLC.

Classificação técnica

Classes Nice

Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Biochip for research or scientific purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devicesbio-cell chips for research or scientific purposes; DNA chip; DNA analysis apparatusscientific apparatus for DNA purification and analysis; DNA sequencing devicesscientific apparatus and instruments for sequencing DNA; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devicesscientific apparatus and instruments for analyzing protein; Protein sequencing devicesscientific apparatus and instruments for sequencing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presenceabsencequantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteinspeptidesDNAaptamerRNAnot for medical purposes; Spectroscopes; Microscopes and parts thereof; Optical scanner; optical measurement components for biological industrial and research use; Computer storage deviceshigh-speed storage subsystems for storage of optical images and measurement records; Biosensorssensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteinsDNAcellsnot for medical purpose; Downloadable images in the field of in vitro diagnosticsnamely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes *none of the foregoing for use in the mammography field or relating to the medical imaging of the breast*

Classe 10

Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic usefor medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materialsproteinscells relevant to diseases; Medical instruments for analyzing and identifying genomic materialsproteinscells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Medical imaging apparatus; Diagnostic measuring apparatus for medical use by analyzing genomic materialsproteins and cells; Apparatus for medicalclinicaldiagnostic uses by analyzing genomic materialsproteinscells related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a conditionnamely genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materialsproteinscells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materialsproteinsbio-samples for medical purposes; Apparatus for testing genomic materialsproteinscells relevant to diseases for medical purposes; Apparatus for tumor diagnosis; Medical apparatus for testing genomic materialsproteinscells relevant to diseasesnamely the cancer and inflammatory disease; Apparatus for analyzing images for medical usefluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materialsproteinsbio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals *Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic usefor medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materialsproteinscells relevant to diseases; Medical instruments for analyzing and identifying genomic materialsproteinscells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Diagnostic measuring apparatus for medical use by analyzing genomic materialsproteins and cells; Apparatus for medicalclinicaldiagnostic uses by analyzing genomic materialsproteinscells related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a conditionnamely genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materialsproteinscells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materialsproteinsbio-samples for medical purposes; Apparatus for testing genomic materialsproteinscells relevant to diseases for medical purposes; Medical apparatus for testing genomic materialsproteinscells relevant to diseasesnamely the cancer and inflammatory disease; Apparatus for analyzing images for medical usefluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materialsproteinsbio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals *; none of the foregoing for use in the mammography field or relating to the medical imaging of the breast*

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

XXXX

POST REGISTRATION ACTION CORRECTION

14/05/2026

WDRL

OTQR WITHDRAWAL FROM PUBLICATION

13/05/2026

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

16/03/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2026

ES7R

TEAS SECTION 7 REQUEST RECEIVED

09/12/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

30/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

30/09/2025

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

04/09/2025

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

26/03/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/02/2025

PUBO

PUBLISHED FOR OPPOSITION

25/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/02/2025

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2025

DOCK

ASSIGNED TO EXAMINER

03/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/01/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/01/2025

ALIE

ASSIGNED TO LIE

06/01/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

27/11/2024

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

25/11/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

29/10/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/08/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/08/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/08/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

14/12/2023

GNSL

LETTER OF SUSPENSION E-MAILED

14/12/2023

CNSL

SUSPENSION LETTER WRITTEN

14/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/11/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/11/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/11/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/08/2023

GNRT

NON-FINAL ACTION E-MAILED

21/08/2023

CNRT

NON-FINAL ACTION WRITTEN

21/08/2023

DOCK

ASSIGNED TO EXAMINER

14/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

21/11/2022

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

15/11/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

15/11/2022

NWAP

NEW APPLICATION ENTERED

07/11/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PI-VIEW ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.